OSTX Financial Statements From 2010 to 2026

OSTX Stock   1.54  0.01  0.65%   
OS Therapies' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing OS Therapies' valuation are provided below:
Market Capitalization
54.2 M
Earnings Share
(0.81)
We have found one hundred fourteen available fundamental measures for OS Therapies, which can be analyzed and compared to other ratios and to its peers in the sector. All investors should make sure to check out all of OS Therapies latest market performance against the performance between 2010 and 2026 to make sure the company can sustain itself this quarter and beyond. Market Cap is likely to drop to about 51.1 M in 2026. Enterprise Value is likely to drop to about 57.6 M in 2026
Check OS Therapies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OS Therapies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.9 K, Interest Expense of 1.8 M or Selling General Administrative of 4.8 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.28 or Days Sales Outstanding of 0.0. OSTX financial statements analysis is a perfect complement when working with OS Therapies Valuation or Volatility modules.
  
Build AI portfolio with OSTX Stock
Check out the analysis of OS Therapies Correlation against competitors.

OS Therapies Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets4.7 MM1.1 B
Slightly volatile
Short and Long Term Debt Total5.2 M5.4 M4.4 B
Slightly volatile
Other Current Liabilities2.5 M2.7 M798.4 M
Slightly volatile
Total Current LiabilitiesM4.2 M1.4 B
Slightly volatile
Property Plant And Equipment Net4.5 K4.7 K1.3 M
Slightly volatile
Accounts Payable1.4 M1.9 M602.4 K
Slightly volatile
Cash4.7 MM798.6 M
Slightly volatile
Non Current Assets Total4.5 K4.7 K1.3 M
Slightly volatile
Cash And Short Term Investments4.7 MM798.6 M
Slightly volatile
Net Receivables979K278.6 M
Slightly volatile
Common Stock Shares Outstanding21 M24 M13.2 M
Slightly volatile
Liabilities And Stockholders Equity4.7 MM1.1 B
Slightly volatile
Non Current Liabilities Total85.5 K90 K3.8 B
Slightly volatile
Other Current Assets642.1 K675.9 K8.5 M
Slightly volatile
Total LiabilitiesM4.3 M5.2 B
Slightly volatile
Total Current Assets4.7 MM1.1 B
Slightly volatile
Short Term Debt12.5 M13.1 M662 M
Slightly volatile
Common Stock17.8 K18.8 K5.7 M
Slightly volatile
Long Term Debt9.6 M11.9 M8.1 M
Slightly volatile
Capital Stock7.3 MM1.2 M
Slightly volatile
Non Current Liabilities Other1.4 M1.7 M1.2 M
Slightly volatile
Short and Long Term Debt11.7 M13.1 M14.4 M
Slightly volatile
Short Term Investments4.4 BB5.4 B
Slightly volatile

OS Therapies Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.9 K3.2 K806
Slightly volatile
Interest Expense1.8 M1.8 M299.6 M
Slightly volatile
Selling General Administrative4.8 M4.6 MM
Slightly volatile
Other Operating Expenses4.5 M7.8 M1.9 M
Slightly volatile
Research Development2.5 M3.3 MM
Slightly volatile
Cost Of Revenue2.4 K2.5 K71.7 K
Pretty Stable
Total Operating Expenses4.2 M7.8 M1.8 M
Slightly volatile
Reconciled Depreciation2.4 K3.2 K1.4 K
Slightly volatile

OS Therapies Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Total Cashflows From Investing Activities979K102.4 M
Slightly volatile
Depreciation2.4 K2.5 K44.1 K
Slightly volatile
Other Non Cash Items1.2 M1.3 M1.7 B
Slightly volatile
Total Cash From Financing Activities10.9 M11.5 M2.3 B
Slightly volatile
End Period Cash Flow4.7 MM798.6 M
Slightly volatile
Other Cashflows From Investing Activities979K103.8 M
Slightly volatile
Net Borrowings2.3 M1.4 M2.8 M
Slightly volatile
Begin Period Cash Flow33.3 K35.1 K891.4 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Dividend Yield0.280.310.3434
Slightly volatile
Average Payables1.1 MM790.3 K
Slightly volatile
Capex To Depreciation14.0113.345.1018
Slightly volatile
Payables Turnover0.00180.001968.8057
Slightly volatile
Cash Per Share0.250.240.1399
Very volatile
Days Payables Outstanding161.4 K196.4 K80.4 K
Slightly volatile
Income Quality0.450.740.4705
Slightly volatile
ROE1.61.530.3626
Slightly volatile
Current Ratio1.131.080.7279
Very volatile
Capex Per Share3.0E-45.0E-43.0E-4
Slightly volatile
Average Receivables625658152 M
Slightly volatile
Interest Debt Per Share0.650.450.6495
Slightly volatile
Debt To Assets1.191.266.0332
Pretty Stable
Days Of Payables Outstanding161.4 K196.4 K80.4 K
Slightly volatile
Ebt Per Ebit1.141.171.1817
Slightly volatile
Quick Ratio1.131.080.7279
Very volatile
Net Income Per E B T8.0E-49.0E-40.001
Slightly volatile
Cash Ratio1.131.080.5827
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio0.80.90.9835
Slightly volatile
Debt Ratio1.191.266.0332
Pretty Stable
Return On Equity1.61.530.3626
Slightly volatile

OS Therapies Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap51.1 M80.4 M60.3 M
Slightly volatile
Enterprise Value57.6 M80.9 M67.1 M
Slightly volatile

OSTX Fundamental Market Drivers

Forward Price Earnings1.6562
Cash And Short Term Investments5.5 M

About OS Therapies Financial Statements

OS Therapies investors use historical fundamental indicators, such as OS Therapies' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in OS Therapies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue2.5 K2.4 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for OSTX Stock Analysis

When running OS Therapies' price analysis, check to measure OS Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OS Therapies is operating at the current time. Most of OS Therapies' value examination focuses on studying past and present price action to predict the probability of OS Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OS Therapies' price. Additionally, you may evaluate how the addition of OS Therapies to your portfolios can decrease your overall portfolio volatility.